Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD Market Closed
Updated: May 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.5B
+2%
Assets
Growth Rates:
1 Year
-1%
3 Years
+1%
5 Years
+6%
7 Years
+19%
10 Years
+10%
1.1B
+4%
Liabilities
Growth Rates:
1 Year
+0%
3 Years
+8%
5 Years
+20%
7 Years
+35%
10 Years
+30%
438.8m
-5%
Equity
Growth Rates:
1 Year
-3%
3 Years
-14%
5 Years
-18%
7 Years
-9%
10 Years
-21%

Balance Sheet Decomposition
Australian Pharmaceutical Industries Ltd

1.5B
Assets
1.1B
Liabilities
1.5B
Assets
1.1B
Liabilities
Current Assets 989.8m
Cash & Short-Term Investments 38.8m
Receivables 589.1m
Other Current Assets 361.9m
Non-Current Assets 540.2m
Long-Term Investments 2.4m
PP&E 230.8m
Intangibles 126.5m
Other Non-Current Assets 180.5m
Current Liabilities 825.5m
Accrued Liabilities 27.2m
Short-Term Debt 20.9m
Other Current Liabilities 777.4m
Non-Current Liabilities 265.7m
Long-Term Debt 246.9m
Other Non-Current Liabilities 18.8m

Balance Sheet
Australian Pharmaceutical Industries Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Aug-2012 Aug-2013 Aug-2014 Aug-2015 Aug-2016 Aug-2017 Aug-2018 Aug-2019 Aug-2020 Aug-2021
Assets
Cash & Cash Equivalents
20
23
24
28
25
40
36
30
61
39
Cash
20
23
24
28
25
40
36
30
61
39
Total Receivables
586
561
566
595
690
682
655
658
538
589
Accounts Receivables
543
529
534
568
660
659
655
658
538
589
Other Receivables
44
32
32
27
29
23
0
0
0
0
Inventory
314
336
343
364
414
399
395
413
368
353
Other Current Assets
0
0
0
7
0
0
0
0
7
9
Total Current Assets
920
919
932
994
1 129
1 121
1 086
1 101
973
990
PP&E Net
121
122
117
102
100
95
101
107
235
231
PP&E Gross
121
122
117
102
100
95
101
107
235
231
Accumulated Depreciation
118
129
139
125
128
135
151
164
173
190
Intangible Assets
100
106
122
148
143
144
178
174
136
126
Note Receivable
76
61
31
30
10
20
27
57
22
10
Long-Term Investments
28
28
7
0
0
0
0
88
1
2
Other Long-Term Assets
37
40
35
23
21
21
24
32
44
42
Other Assets
92
101
45
46
47
50
105
106
128
129
Total Assets
1 373
N/A
1 376
+0%
1 289
-6%
1 343
+4%
1 450
+8%
1 451
+0%
1 521
+5%
1 665
+9%
1 540
-8%
1 530
-1%
Liabilities
Accounts Payable
530
562
567
609
749
752
0
0
0
0
Accrued Liabilities
48
61
67
80
73
72
22
22
23
27
Short-Term Debt
4
4
3
2
1
2
2
5
8
21
Current Portion of Long-Term Debt
40
22
18
57
2
1
1
55
40
46
Other Current Liabilities
42
13
32
30
21
25
15
15
19
11
Total Current Liabilities
663
661
687
778
846
851
818
887
833
825
Long-Term Debt
0
0
14
41
48
30
89
170
212
247
Deferred Income Tax
0
0
0
0
1
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
2
3
4
2
Other Liabilities
142
131
108
19
18
16
103
86
40
17
Total Liabilities
805
N/A
792
-2%
808
+2%
837
+4%
913
+9%
897
-2%
1 013
+13%
1 146
+13%
1 089
-5%
1 091
+0%
Equity
Common Stock
567
567
567
566
566
566
566
566
566
566
Retained Earnings
11
21
85
60
31
12
58
50
116
130
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
1
0
0
Other Equity
9
3
1
1
1
0
1
1
0
3
Total Equity
568
N/A
584
+3%
481
-18%
505
+5%
537
+6%
554
+3%
509
-8%
519
+2%
451
-13%
439
-3%
Total Liabilities & Equity
1 373
N/A
1 376
+0%
1 289
-6%
1 343
+4%
1 450
+8%
1 451
+0%
1 521
+5%
1 665
+9%
1 540
-8%
1 530
-1%
Shares Outstanding
Common Shares Outstanding
488
488
488
488
489
490
492
493
493
493

See Also

Summary
API intrinsic value, competitors valuation, and company profile.
DCF Valuation
API stock valuation using Discount Cash Flow valuation method.
Relative Valuation
API stock valuation using valuation multiples.
Wall Street Estimates
API price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
API stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.